

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular visceral epithelial cell development (GO:0072015) | 6.10990810 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.69430543 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.48253170 |
| 4 | glomerular epithelial cell development (GO:0072310) | 5.41061803 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.37313797 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.75116936 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.74775892 |
| 8 | glutamate secretion (GO:0014047) | 4.63989718 |
| 9 | cellular ketone body metabolic process (GO:0046950) | 4.62331732 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.60377560 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.49043501 |
| 12 | vocalization behavior (GO:0071625) | 4.46864707 |
| 13 | protein localization to synapse (GO:0035418) | 4.37776628 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34716531 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.32302407 |
| 16 | glomerular basement membrane development (GO:0032836) | 4.17207125 |
| 17 | ketone body metabolic process (GO:1902224) | 4.17065174 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.11676295 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.09704625 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.01028566 |
| 21 | exploration behavior (GO:0035640) | 3.94992854 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.86915308 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76299783 |
| 24 | neuron recognition (GO:0008038) | 3.74258320 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 3.69754778 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.69527432 |
| 27 | cellular potassium ion homeostasis (GO:0030007) | 3.69145026 |
| 28 | proline transport (GO:0015824) | 3.68738881 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.64490016 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 3.59357200 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.58960381 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.57929649 |
| 33 | long-term memory (GO:0007616) | 3.53669086 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.49741554 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 3.48315857 |
| 36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48177270 |
| 37 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.46913157 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.46866485 |
| 39 | regulation of synapse structural plasticity (GO:0051823) | 3.42586862 |
| 40 | sodium ion export (GO:0071436) | 3.40447382 |
| 41 | axonal fasciculation (GO:0007413) | 3.37588798 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35284955 |
| 43 | regulation of vesicle fusion (GO:0031338) | 3.31134648 |
| 44 | innervation (GO:0060384) | 3.31077534 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.22342780 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.21610358 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.20437588 |
| 48 | regulation of cilium movement (GO:0003352) | 3.18544881 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17731997 |
| 50 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.17490758 |
| 51 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.16677337 |
| 52 | neurotransmitter transport (GO:0006836) | 3.16260837 |
| 53 | regulation of glucokinase activity (GO:0033131) | 3.16013588 |
| 54 | regulation of hexokinase activity (GO:1903299) | 3.16013588 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.13353806 |
| 56 | positive regulation of membrane potential (GO:0045838) | 3.12700476 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.12439762 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 3.12236403 |
| 59 | cell communication by electrical coupling (GO:0010644) | 3.11873144 |
| 60 | regulation of axon guidance (GO:1902667) | 3.09784713 |
| 61 | glomerulus development (GO:0032835) | 3.09769804 |
| 62 | regulation of postsynaptic membrane potential (GO:0060078) | 3.09739161 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.09107499 |
| 64 | postsynaptic membrane organization (GO:0001941) | 3.07703834 |
| 65 | vesicle transport along microtubule (GO:0047496) | 3.07469474 |
| 66 | dendrite morphogenesis (GO:0048813) | 3.05406487 |
| 67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04533913 |
| 68 | positive regulation of synapse maturation (GO:0090129) | 3.03828601 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.01289775 |
| 70 | reverse cholesterol transport (GO:0043691) | 2.99976939 |
| 71 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.99911445 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.99838142 |
| 73 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.98822225 |
| 74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97429340 |
| 75 | chemosensory behavior (GO:0007635) | 2.94962405 |
| 76 | neuromuscular process controlling posture (GO:0050884) | 2.93537817 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.93238842 |
| 78 | presynaptic membrane assembly (GO:0097105) | 2.90338877 |
| 79 | neuronal action potential (GO:0019228) | 2.89256348 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 2.87980990 |
| 81 | presynaptic membrane organization (GO:0097090) | 2.87309699 |
| 82 | membrane hyperpolarization (GO:0060081) | 2.85796452 |
| 83 | cell migration in hindbrain (GO:0021535) | 2.85777047 |
| 84 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.85261818 |
| 85 | behavioral defense response (GO:0002209) | 2.85041906 |
| 86 | behavioral fear response (GO:0001662) | 2.85041906 |
| 87 | organelle transport along microtubule (GO:0072384) | 2.84417597 |
| 88 | regulation of neurotransmitter levels (GO:0001505) | 2.84044548 |
| 89 | response to histamine (GO:0034776) | 2.80756218 |
| 90 | long-term synaptic potentiation (GO:0060291) | 2.80465272 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79078966 |
| 92 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.76425867 |
| 93 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.75908741 |
| 94 | cardiac right ventricle morphogenesis (GO:0003215) | 2.75103347 |
| 95 | membrane depolarization (GO:0051899) | 2.75060501 |
| 96 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.74810680 |
| 97 | transmission of nerve impulse (GO:0019226) | 2.74143754 |
| 98 | neuromuscular process (GO:0050905) | 2.73859452 |
| 99 | startle response (GO:0001964) | 2.73448584 |
| 100 | glycerophospholipid catabolic process (GO:0046475) | 2.73125283 |
| 101 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.72983354 |
| 102 | mating behavior (GO:0007617) | 2.72445721 |
| 103 | glycine transport (GO:0015816) | 2.72265563 |
| 104 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.70519725 |
| 105 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.70506159 |
| 106 | response to auditory stimulus (GO:0010996) | 2.70205587 |
| 107 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.70127994 |
| 108 | synaptic transmission (GO:0007268) | 2.69587568 |
| 109 | regulation of cholesterol esterification (GO:0010872) | 2.69527724 |
| 110 | synapse assembly (GO:0007416) | 2.68288610 |
| 111 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.68214766 |
| 112 | dopamine receptor signaling pathway (GO:0007212) | 2.67124536 |
| 113 | fear response (GO:0042596) | 2.66935473 |
| 114 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.66810191 |
| 115 | bile acid biosynthetic process (GO:0006699) | 2.66087443 |
| 116 | rhodopsin mediated signaling pathway (GO:0016056) | 2.65671368 |
| 117 | suckling behavior (GO:0001967) | 2.64528474 |
| 118 | nucleobase catabolic process (GO:0046113) | 2.61564465 |
| 119 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.60969174 |
| 120 | keratinocyte development (GO:0003334) | 2.60820616 |
| 121 | axoneme assembly (GO:0035082) | 2.57803583 |
| 122 | vagina development (GO:0060068) | 2.57618640 |
| 123 | L-fucose metabolic process (GO:0042354) | 2.57494695 |
| 124 | L-fucose catabolic process (GO:0042355) | 2.57494695 |
| 125 | fucose catabolic process (GO:0019317) | 2.57494695 |
| 126 | heme transport (GO:0015886) | 2.55502555 |
| 127 | uterus development (GO:0060065) | 2.53120815 |
| 128 | glycosphingolipid biosynthetic process (GO:0006688) | 2.52372459 |
| 129 | regulation of microtubule-based movement (GO:0060632) | 2.51108529 |
| 130 | iron coordination entity transport (GO:1901678) | 2.50857166 |
| 131 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.50604791 |
| 132 | epithelial cilium movement (GO:0003351) | 2.45549479 |
| 133 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.44183129 |
| 134 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44150073 |
| 135 | cellular response to leptin stimulus (GO:0044320) | 2.42929046 |
| 136 | piRNA metabolic process (GO:0034587) | 2.40975289 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 2.40136292 |
| 138 | C4-dicarboxylate transport (GO:0015740) | 2.40085079 |
| 139 | serotonin metabolic process (GO:0042428) | 2.38861750 |
| 140 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.37827960 |
| 141 | establishment of pigment granule localization (GO:0051905) | 2.37403163 |
| 142 | short-chain fatty acid metabolic process (GO:0046459) | 2.37211319 |
| 143 | nonmotile primary cilium assembly (GO:0035058) | 2.36716029 |
| 144 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.33762958 |
| 145 | female genitalia development (GO:0030540) | 2.32634163 |
| 146 | auditory receptor cell stereocilium organization (GO:0060088) | 2.31613987 |
| 147 | reflex (GO:0060004) | 2.30594520 |
| 148 | prostate gland growth (GO:0060736) | 2.30086941 |
| 149 | cilium movement (GO:0003341) | 2.30014651 |
| 150 | branched-chain amino acid catabolic process (GO:0009083) | 2.29328094 |
| 151 | action potential (GO:0001508) | 2.29216726 |
| 152 | endocrine pancreas development (GO:0031018) | 2.28178528 |
| 153 | otic vesicle formation (GO:0030916) | 2.27913314 |
| 154 | cellular biogenic amine catabolic process (GO:0042402) | 2.26237077 |
| 155 | amine catabolic process (GO:0009310) | 2.26237077 |
| 156 | regulation of female receptivity (GO:0045924) | 2.25764317 |
| 157 | nitric oxide mediated signal transduction (GO:0007263) | 2.25379096 |
| 158 | phospholipid homeostasis (GO:0055091) | 2.24925288 |
| 159 | detection of light stimulus involved in visual perception (GO:0050908) | 2.24651148 |
| 160 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.24651148 |
| 161 | phospholipid efflux (GO:0033700) | 2.24342096 |
| 162 | norepinephrine metabolic process (GO:0042415) | 2.23237236 |
| 163 | response to leptin (GO:0044321) | 2.21885821 |
| 164 | regulation of action potential (GO:0098900) | 2.21652096 |
| 165 | establishment of melanosome localization (GO:0032401) | 2.20723294 |
| 166 | pigment granule transport (GO:0051904) | 2.20603686 |
| 167 | polyol catabolic process (GO:0046174) | 2.19793185 |
| 168 | pigment granule localization (GO:0051875) | 2.18248158 |
| 169 | positive regulation of meiosis (GO:0045836) | 2.17854427 |
| 170 | protein localization to cilium (GO:0061512) | 2.15746887 |
| 171 | dopamine transport (GO:0015872) | 2.15376963 |
| 172 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.15067276 |
| 173 | L-phenylalanine catabolic process (GO:0006559) | 2.15067276 |
| 174 | auditory behavior (GO:0031223) | 2.14858584 |
| 175 | limb bud formation (GO:0060174) | 2.14248855 |
| 176 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.13587046 |
| 177 | intestinal epithelial cell development (GO:0060576) | 2.13072914 |
| 178 | primary amino compound metabolic process (GO:1901160) | 2.12069319 |
| 179 | response to dietary excess (GO:0002021) | 2.11777233 |
| 180 | toxin metabolic process (GO:0009404) | 2.11507227 |
| 181 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.11479266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.62561602 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21008701 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00837036 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93805425 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87289614 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64508051 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64508051 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60163666 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55422383 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51784826 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51160366 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46579463 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45332704 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38667810 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35265754 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.28573727 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26946350 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25263150 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24908693 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.24505524 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12918010 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.11234705 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05144717 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.04755916 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.03688542 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99932977 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.94988150 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93748462 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83312385 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82630608 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65999425 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.65640648 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65626077 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64271569 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61516969 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.59067808 |
| 37 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.57274906 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56401749 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56312896 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55493687 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55323188 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54413526 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49406252 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48256916 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45262376 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45187955 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43844509 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42153414 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40018456 |
| 50 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.38595975 |
| 51 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37324458 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36814721 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33692267 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32738970 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32573228 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31028746 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30102811 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30084421 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29375714 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28806906 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28409896 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28409896 |
| 63 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26976370 |
| 64 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26937222 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26892404 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26404630 |
| 67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26232694 |
| 68 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.25728885 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22869866 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22616004 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22455239 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22348657 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20836228 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20427388 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20351036 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20204464 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18717715 |
| 78 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18698032 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17878648 |
| 80 | AR_19668381_ChIP-Seq_PC3_Human | 1.17302223 |
| 81 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15098514 |
| 82 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14138713 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14138713 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13988999 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13584751 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12959399 |
| 87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12817930 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12500294 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12365531 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12265794 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11310729 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10782605 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10728157 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10454075 |
| 95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10011069 |
| 96 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09811126 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09385654 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08833977 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08552082 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06654661 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06375859 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05567147 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04299355 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03958239 |
| 105 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03257666 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03123991 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.02882050 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02420978 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01639378 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01210942 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00877460 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00838305 |
| 113 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00326843 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97952290 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96182611 |
| 116 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95679491 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94682791 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94277283 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93383110 |
| 120 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92388815 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92105464 |
| 122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91886654 |
| 123 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91637287 |
| 124 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90277412 |
| 125 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89221499 |
| 126 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88766895 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88015026 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87578137 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87328267 |
| 130 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87328267 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86638125 |
| 132 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86615510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.97373425 |
| 2 | MP0003880_abnormal_central_pattern | 4.35695506 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.80036436 |
| 4 | MP0004270_analgesia | 3.45398756 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.08311690 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.98265169 |
| 7 | MP0009745_abnormal_behavioral_response | 2.94352412 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.79808186 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.78004831 |
| 10 | MP0002064_seizures | 2.71216188 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.63328234 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.57719704 |
| 13 | MP0009046_muscle_twitch | 2.56927139 |
| 14 | MP0003195_calcinosis | 2.51909837 |
| 15 | MP0001486_abnormal_startle_reflex | 2.50898093 |
| 16 | MP0002272_abnormal_nervous_system | 2.39736643 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.27466527 |
| 18 | MP0002736_abnormal_nociception_after | 2.22985086 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.20955291 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.11270896 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.05810695 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.04633713 |
| 23 | MP0002184_abnormal_innervation | 2.02459063 |
| 24 | MP0001970_abnormal_pain_threshold | 2.01280462 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.92288584 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.92176177 |
| 27 | MP0004858_abnormal_nervous_system | 1.89558749 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.85078686 |
| 29 | MP0000778_abnormal_nervous_system | 1.84884626 |
| 30 | MP0001984_abnormal_olfaction | 1.82254199 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.81874106 |
| 32 | MP0008995_early_reproductive_senescence | 1.81025176 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.79667234 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.79473332 |
| 35 | MP0002822_catalepsy | 1.66295354 |
| 36 | MP0003787_abnormal_imprinting | 1.65716148 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.61315917 |
| 38 | MP0003123_paternal_imprinting | 1.59254629 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.58641654 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.57126336 |
| 41 | MP0008569_lethality_at_weaning | 1.57057453 |
| 42 | MP0003329_amyloid_beta_deposits | 1.55601697 |
| 43 | MP0004885_abnormal_endolymph | 1.54661964 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.54295257 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.54077731 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.51936483 |
| 47 | MP0003011_delayed_dark_adaptation | 1.51606631 |
| 48 | MP0004133_heterotaxia | 1.48520358 |
| 49 | MP0003879_abnormal_hair_cell | 1.48398444 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.47659449 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47160115 |
| 52 | MP0000955_abnormal_spinal_cord | 1.45388444 |
| 53 | MP0004924_abnormal_behavior | 1.41207074 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.41207074 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.37625276 |
| 56 | MP0002229_neurodegeneration | 1.36589227 |
| 57 | MP0000427_abnormal_hair_cycle | 1.35819790 |
| 58 | MP0002066_abnormal_motor_capabilities/c | 1.34544042 |
| 59 | MP0005253_abnormal_eye_physiology | 1.31818529 |
| 60 | MP0001905_abnormal_dopamine_level | 1.31043007 |
| 61 | MP0003121_genomic_imprinting | 1.24787555 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.19357655 |
| 63 | MP0003283_abnormal_digestive_organ | 1.19163852 |
| 64 | MP0000639_abnormal_adrenal_gland | 1.18709321 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.18042516 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 1.16361292 |
| 67 | MP0003122_maternal_imprinting | 1.15374926 |
| 68 | MP0003890_abnormal_embryonic-extraembry | 1.14911499 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.13312057 |
| 70 | MP0002160_abnormal_reproductive_system | 1.10180425 |
| 71 | MP0002090_abnormal_vision | 1.08016648 |
| 72 | MP0005365_abnormal_bile_salt | 1.07160139 |
| 73 | MP0000462_abnormal_digestive_system | 1.05198669 |
| 74 | MP0003633_abnormal_nervous_system | 1.04134216 |
| 75 | MP0002152_abnormal_brain_morphology | 1.03736098 |
| 76 | MP0000538_abnormal_urinary_bladder | 1.03617292 |
| 77 | MP0001963_abnormal_hearing_physiology | 1.02079226 |
| 78 | MP0002102_abnormal_ear_morphology | 1.01961451 |
| 79 | MP0004043_abnormal_pH_regulation | 1.01905363 |
| 80 | MP0002751_abnormal_autonomic_nervous | 0.96161700 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.96144978 |
| 82 | MP0000383_abnormal_hair_follicle | 0.94661321 |
| 83 | MP0001944_abnormal_pancreas_morphology | 0.94495797 |
| 84 | MP0003634_abnormal_glial_cell | 0.93986005 |
| 85 | MP0001188_hyperpigmentation | 0.91982794 |
| 86 | MP0003631_nervous_system_phenotype | 0.90373615 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.90289757 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.89560992 |
| 89 | MP0005670_abnormal_white_adipose | 0.88740150 |
| 90 | MP0008872_abnormal_physiological_respon | 0.88562194 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.88444180 |
| 92 | MP0005195_abnormal_posterior_eye | 0.88241595 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.87947732 |
| 94 | MP0002069_abnormal_eating/drinking_beha | 0.87588065 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.87224429 |
| 96 | MP0005499_abnormal_olfactory_system | 0.86304257 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.86304257 |
| 98 | MP0004142_abnormal_muscle_tone | 0.86004042 |
| 99 | MP0004085_abnormal_heartbeat | 0.84193988 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.83949910 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.82508685 |
| 102 | MP0004742_abnormal_vestibular_system | 0.82467617 |
| 103 | MP0005535_abnormal_body_temperature | 0.81030658 |
| 104 | MP0002938_white_spotting | 0.80071930 |
| 105 | MP0009840_abnormal_foam_cell | 0.79747697 |
| 106 | MP0001529_abnormal_vocalization | 0.79653282 |
| 107 | MP0004084_abnormal_cardiac_muscle | 0.79620999 |
| 108 | MP0000534_abnormal_ureter_morphology | 0.79394136 |
| 109 | MP0000569_abnormal_digit_pigmentation | 0.79335289 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.78784635 |
| 111 | MP0003878_abnormal_ear_physiology | 0.78354322 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 0.78354322 |
| 113 | MP0005332_abnormal_amino_acid | 0.78237899 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.78025279 |
| 115 | MP0000516_abnormal_urinary_system | 0.78025279 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.77819932 |
| 117 | MP0004145_abnormal_muscle_electrophysio | 0.77072656 |
| 118 | MP0004484_altered_response_of | 0.76614382 |
| 119 | MP0004036_abnormal_muscle_relaxation | 0.75347332 |
| 120 | MP0005187_abnormal_penis_morphology | 0.74688617 |
| 121 | MP0001664_abnormal_digestion | 0.74205472 |
| 122 | MP0003119_abnormal_digestive_system | 0.73518296 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.72863084 |
| 124 | MP0004233_abnormal_muscle_weight | 0.66249907 |
| 125 | MP0008874_decreased_physiological_sensi | 0.65561283 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.65453154 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.64596574 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.63367364 |
| 129 | MP0004510_myositis | 0.62845843 |
| 130 | MP0002234_abnormal_pharynx_morphology | 0.61617730 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.61341598 |
| 132 | MP0003632_abnormal_nervous_system | 0.61326756 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.60377239 |
| 134 | MP0000604_amyloidosis | 0.60214224 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.58174571 |
| 136 | MP0000631_abnormal_neuroendocrine_gland | 0.58001542 |
| 137 | MP0001177_atelectasis | 0.56858101 |
| 138 | MP0001765_abnormal_ion_homeostasis | 0.55947263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.10391991 |
| 2 | Myokymia (HP:0002411) | 5.81212311 |
| 3 | Visual hallucinations (HP:0002367) | 4.85143415 |
| 4 | Focal seizures (HP:0007359) | 4.65466158 |
| 5 | Febrile seizures (HP:0002373) | 4.07253542 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.02082833 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.86138808 |
| 8 | Chronic hepatic failure (HP:0100626) | 3.85164819 |
| 9 | Focal segmental glomerulosclerosis (HP:0000097) | 3.80681167 |
| 10 | Atonic seizures (HP:0010819) | 3.76335608 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.71696405 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.49934389 |
| 13 | Action tremor (HP:0002345) | 3.45858634 |
| 14 | Absence seizures (HP:0002121) | 3.45551909 |
| 15 | Central scotoma (HP:0000603) | 3.22799719 |
| 16 | Abnormality of macular pigmentation (HP:0008002) | 3.19307641 |
| 17 | Pancreatic cysts (HP:0001737) | 3.18852938 |
| 18 | Ankle clonus (HP:0011448) | 3.16935915 |
| 19 | Mesangial abnormality (HP:0001966) | 3.16468349 |
| 20 | Dialeptic seizures (HP:0011146) | 3.11580524 |
| 21 | Mutism (HP:0002300) | 3.11265724 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.11185736 |
| 23 | Concave nail (HP:0001598) | 3.11062706 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 3.10813349 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 3.10813349 |
| 26 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.10640583 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 3.10563759 |
| 28 | True hermaphroditism (HP:0010459) | 3.10437850 |
| 29 | Ketoacidosis (HP:0001993) | 3.01240911 |
| 30 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.92891530 |
| 31 | Glomerulosclerosis (HP:0000096) | 2.88820938 |
| 32 | Polyphagia (HP:0002591) | 2.86787007 |
| 33 | Hypothermia (HP:0002045) | 2.85527192 |
| 34 | Depression (HP:0000716) | 2.82881215 |
| 35 | Increased circulating renin level (HP:0000848) | 2.80067871 |
| 36 | Rapidly progressive (HP:0003678) | 2.76515253 |
| 37 | Pheochromocytoma (HP:0002666) | 2.71186851 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.69560675 |
| 39 | Pancreatic fibrosis (HP:0100732) | 2.67739291 |
| 40 | Truncal ataxia (HP:0002078) | 2.67112169 |
| 41 | Abnormal pancreas size (HP:0012094) | 2.66401586 |
| 42 | Broad-based gait (HP:0002136) | 2.66368344 |
| 43 | Ketosis (HP:0001946) | 2.63631447 |
| 44 | Nephrogenic diabetes insipidus (HP:0009806) | 2.60433010 |
| 45 | Papilledema (HP:0001085) | 2.59544340 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.58377765 |
| 47 | Congenital primary aphakia (HP:0007707) | 2.57989939 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.55887031 |
| 49 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.53029526 |
| 50 | Poor eye contact (HP:0000817) | 2.52481851 |
| 51 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.52236106 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.50076910 |
| 53 | Anxiety (HP:0000739) | 2.49890294 |
| 54 | Nephronophthisis (HP:0000090) | 2.49718277 |
| 55 | Hypomagnesemia (HP:0002917) | 2.49631761 |
| 56 | Limb dystonia (HP:0002451) | 2.48029749 |
| 57 | Testicular neoplasm (HP:0010788) | 2.47259936 |
| 58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.44995151 |
| 59 | Renal cortical cysts (HP:0000803) | 2.44356998 |
| 60 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.44202992 |
| 61 | Drooling (HP:0002307) | 2.42506062 |
| 62 | Excessive salivation (HP:0003781) | 2.42506062 |
| 63 | Abnormality of the renal cortex (HP:0011035) | 2.40948381 |
| 64 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40856200 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.40148142 |
| 66 | Abnormal albumin level (HP:0012116) | 2.39931463 |
| 67 | Hypoalbuminemia (HP:0003073) | 2.39931463 |
| 68 | Large for gestational age (HP:0001520) | 2.39839965 |
| 69 | Male pseudohermaphroditism (HP:0000037) | 2.39346044 |
| 70 | Amblyopia (HP:0000646) | 2.38709075 |
| 71 | Spontaneous abortion (HP:0005268) | 2.35268883 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.34446552 |
| 73 | Scotoma (HP:0000575) | 2.33827514 |
| 74 | Gaze-evoked nystagmus (HP:0000640) | 2.32870535 |
| 75 | Dyschromatopsia (HP:0007641) | 2.32294383 |
| 76 | Postural instability (HP:0002172) | 2.30806501 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.29920749 |
| 78 | Progressive inability to walk (HP:0002505) | 2.29740097 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.29219019 |
| 80 | Impaired social interactions (HP:0000735) | 2.28800386 |
| 81 | Abnormal social behavior (HP:0012433) | 2.28800386 |
| 82 | Agitation (HP:0000713) | 2.27871563 |
| 83 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27673682 |
| 84 | Genetic anticipation (HP:0003743) | 2.27493710 |
| 85 | Gait imbalance (HP:0002141) | 2.26933842 |
| 86 | Dysmetria (HP:0001310) | 2.26829794 |
| 87 | Cystic liver disease (HP:0006706) | 2.24378702 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 2.23991537 |
| 89 | Dysdiadochokinesis (HP:0002075) | 2.23917855 |
| 90 | Stage 5 chronic kidney disease (HP:0003774) | 2.20586592 |
| 91 | Spastic gait (HP:0002064) | 2.19774776 |
| 92 | Hyperventilation (HP:0002883) | 2.19384255 |
| 93 | Enlarged penis (HP:0000040) | 2.18347580 |
| 94 | Hyperglycinemia (HP:0002154) | 2.16483851 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.14917125 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 2.14774764 |
| 97 | Neurofibrillary tangles (HP:0002185) | 2.11834461 |
| 98 | Urinary urgency (HP:0000012) | 2.11598964 |
| 99 | Torticollis (HP:0000473) | 2.10249343 |
| 100 | Abnormality of the renal medulla (HP:0100957) | 2.09488988 |
| 101 | Retinal atrophy (HP:0001105) | 2.09348159 |
| 102 | Bradykinesia (HP:0002067) | 2.08069506 |
| 103 | Gonadal dysgenesis (HP:0000133) | 2.08037672 |
| 104 | Abolished electroretinogram (ERG) (HP:0000550) | 2.07252476 |
| 105 | J-shaped sella turcica (HP:0002680) | 2.07231420 |
| 106 | Intention tremor (HP:0002080) | 2.05615080 |
| 107 | Hyperglycemia (HP:0003074) | 2.05011708 |
| 108 | Cerebral inclusion bodies (HP:0100314) | 2.04614065 |
| 109 | Choroideremia (HP:0001139) | 2.04528275 |
| 110 | Abnormal drinking behavior (HP:0030082) | 1.99238090 |
| 111 | Polydipsia (HP:0001959) | 1.99238090 |
| 112 | Nephrotic syndrome (HP:0000100) | 1.99166712 |
| 113 | Lower limb muscle weakness (HP:0007340) | 1.99079835 |
| 114 | Hyperglycinuria (HP:0003108) | 1.98959326 |
| 115 | Failure to thrive in infancy (HP:0001531) | 1.97521163 |
| 116 | Absent/shortened dynein arms (HP:0200106) | 1.96234467 |
| 117 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.96234467 |
| 118 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95804431 |
| 119 | Megalencephaly (HP:0001355) | 1.95681227 |
| 120 | Decreased central vision (HP:0007663) | 1.94991704 |
| 121 | Abnormality of alanine metabolism (HP:0010916) | 1.94478795 |
| 122 | Hyperalaninemia (HP:0003348) | 1.94478795 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94478795 |
| 124 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.94158907 |
| 125 | Insomnia (HP:0100785) | 1.93321743 |
| 126 | Poor coordination (HP:0002370) | 1.93068376 |
| 127 | Abnormal EKG (HP:0003115) | 1.92550394 |
| 128 | Inability to walk (HP:0002540) | 1.92475746 |
| 129 | Tachypnea (HP:0002789) | 1.92383915 |
| 130 | Disproportionate short-trunk short stature (HP:0003521) | 1.92053727 |
| 131 | Diplopia (HP:0000651) | 1.91751461 |
| 132 | Abnormality of binocular vision (HP:0011514) | 1.91751461 |
| 133 | Tubulointerstitial nephritis (HP:0001970) | 1.89409712 |
| 134 | Sex reversal (HP:0012245) | 1.88544482 |
| 135 | Abnormal sex determination (HP:0012244) | 1.88544482 |
| 136 | Impaired smooth pursuit (HP:0007772) | 1.87534062 |
| 137 | Abnormality of magnesium homeostasis (HP:0004921) | 1.87475956 |
| 138 | Genital tract atresia (HP:0001827) | 1.86434791 |
| 139 | Fetal akinesia sequence (HP:0001989) | 1.86358080 |
| 140 | Aqueductal stenosis (HP:0002410) | 1.85736280 |
| 141 | Bundle branch block (HP:0011710) | 1.85589126 |
| 142 | Hypercortisolism (HP:0001578) | 1.84914165 |
| 143 | Absent speech (HP:0001344) | 1.84540818 |
| 144 | Focal dystonia (HP:0004373) | 1.84210012 |
| 145 | Vaginal atresia (HP:0000148) | 1.83052405 |
| 146 | Type II lissencephaly (HP:0007260) | 1.82663300 |
| 147 | Keratoconus (HP:0000563) | 1.82258191 |
| 148 | Increased corneal curvature (HP:0100692) | 1.82258191 |
| 149 | Methylmalonic aciduria (HP:0012120) | 1.81366850 |
| 150 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.81034868 |
| 151 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.81034868 |
| 152 | Hemiparesis (HP:0001269) | 1.80576403 |
| 153 | Abnormality of vitamin B metabolism (HP:0004340) | 1.80263030 |
| 154 | Tongue fasciculations (HP:0001308) | 1.80091906 |
| 155 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79556228 |
| 156 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79556228 |
| 157 | Hip dysplasia (HP:0001385) | 1.79301220 |
| 158 | Type II diabetes mellitus (HP:0005978) | 1.78604331 |
| 159 | Hemiplegia (HP:0002301) | 1.78330432 |
| 160 | Anosmia (HP:0000458) | 1.77660456 |
| 161 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.77574211 |
| 162 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.77574211 |
| 163 | Retinal dysplasia (HP:0007973) | 1.77426194 |
| 164 | Intrahepatic cholestasis (HP:0001406) | 1.76583075 |
| 165 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.74979074 |
| 166 | Abnormality of glycine metabolism (HP:0010895) | 1.74979074 |
| 167 | Abnormal ciliary motility (HP:0012262) | 1.73331242 |
| 168 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.70540825 |
| 169 | Muscular hypotonia of the trunk (HP:0008936) | 1.68772762 |
| 170 | Severe muscular hypotonia (HP:0006829) | 1.67876704 |
| 171 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.67626030 |
| 172 | Polyuria (HP:0000103) | 1.67088805 |
| 173 | Decreased circulating renin level (HP:0003351) | 1.64574431 |
| 174 | Cerebellar dysplasia (HP:0007033) | 1.64472580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.34867609 |
| 2 | NTRK3 | 4.69558800 |
| 3 | MARK1 | 3.64804052 |
| 4 | MAP3K9 | 3.58721160 |
| 5 | MAP3K4 | 3.01045812 |
| 6 | EPHA4 | 2.75379654 |
| 7 | TRIM28 | 2.74041989 |
| 8 | MINK1 | 2.61101483 |
| 9 | MAP2K7 | 2.45572848 |
| 10 | BMPR1B | 2.17771282 |
| 11 | PAK6 | 2.13383575 |
| 12 | NTRK1 | 2.11536620 |
| 13 | MAP4K2 | 2.10270639 |
| 14 | PRKD3 | 2.09629073 |
| 15 | FGFR2 | 2.06647747 |
| 16 | KSR2 | 1.92531537 |
| 17 | GRK5 | 1.89672983 |
| 18 | PDK2 | 1.82214334 |
| 19 | WNK4 | 1.79840991 |
| 20 | DAPK2 | 1.77899574 |
| 21 | NTRK2 | 1.76683263 |
| 22 | PIK3CA | 1.64395314 |
| 23 | MAP2K4 | 1.62495527 |
| 24 | ADRBK2 | 1.60133871 |
| 25 | CDK5 | 1.54923055 |
| 26 | MAPK13 | 1.54758852 |
| 27 | MAP3K12 | 1.53746071 |
| 28 | ACVR1B | 1.50877056 |
| 29 | CAMKK1 | 1.49133355 |
| 30 | OXSR1 | 1.47329644 |
| 31 | CASK | 1.47008107 |
| 32 | PINK1 | 1.40960285 |
| 33 | RIPK4 | 1.40217157 |
| 34 | ARAF | 1.37482284 |
| 35 | TAOK3 | 1.35354722 |
| 36 | SIK2 | 1.35186248 |
| 37 | PHKG1 | 1.33997039 |
| 38 | PHKG2 | 1.33997039 |
| 39 | PRPF4B | 1.32157827 |
| 40 | STK38 | 1.29059986 |
| 41 | LATS2 | 1.27424674 |
| 42 | NUAK1 | 1.22521762 |
| 43 | MAP3K2 | 1.22228418 |
| 44 | PRKCG | 1.21037092 |
| 45 | KSR1 | 1.20460520 |
| 46 | PLK2 | 1.18501480 |
| 47 | BCR | 1.17155636 |
| 48 | STK39 | 1.17052110 |
| 49 | NEK1 | 1.16025808 |
| 50 | MAP3K13 | 1.14588880 |
| 51 | PAK3 | 1.14466237 |
| 52 | CAMK2B | 1.13776639 |
| 53 | AKT3 | 1.12720205 |
| 54 | MAPKAPK3 | 1.11529577 |
| 55 | PNCK | 1.06442205 |
| 56 | SGK494 | 1.05153897 |
| 57 | SGK223 | 1.05153897 |
| 58 | STK38L | 1.04783981 |
| 59 | RET | 1.01935240 |
| 60 | DAPK1 | 1.01529046 |
| 61 | LMTK2 | 1.00977781 |
| 62 | UHMK1 | 0.98930294 |
| 63 | CAMKK2 | 0.98868241 |
| 64 | CSNK1G1 | 0.98470134 |
| 65 | CSNK1G3 | 0.97142968 |
| 66 | MUSK | 0.96123182 |
| 67 | CAMK2A | 0.93854698 |
| 68 | SGK2 | 0.93788068 |
| 69 | TNK2 | 0.92563035 |
| 70 | PRKCH | 0.92065428 |
| 71 | PKN2 | 0.89147712 |
| 72 | TNIK | 0.88222237 |
| 73 | EIF2AK3 | 0.85412892 |
| 74 | EPHB2 | 0.85373495 |
| 75 | CDK19 | 0.85058303 |
| 76 | NME1 | 0.84403037 |
| 77 | DYRK2 | 0.83875491 |
| 78 | TIE1 | 0.83609511 |
| 79 | GRK1 | 0.82113845 |
| 80 | CDK18 | 0.81390064 |
| 81 | SGK3 | 0.81334681 |
| 82 | FES | 0.80505620 |
| 83 | PRKCE | 0.80362921 |
| 84 | CDK15 | 0.80273221 |
| 85 | CDK14 | 0.78927830 |
| 86 | DYRK1A | 0.78657787 |
| 87 | CSNK1G2 | 0.78217278 |
| 88 | FER | 0.76855135 |
| 89 | WNK1 | 0.74865961 |
| 90 | ZAK | 0.72660131 |
| 91 | STK11 | 0.72630608 |
| 92 | CAMK1 | 0.70978997 |
| 93 | PBK | 0.69877017 |
| 94 | SGK1 | 0.69185187 |
| 95 | CDK11A | 0.68307229 |
| 96 | PRKCZ | 0.66750541 |
| 97 | TAOK1 | 0.66266202 |
| 98 | MARK2 | 0.66067060 |
| 99 | CDC42BPA | 0.65710965 |
| 100 | CSNK1D | 0.64942928 |
| 101 | WNK3 | 0.64064260 |
| 102 | CSNK1A1 | 0.61538383 |
| 103 | ALK | 0.59297232 |
| 104 | SIK3 | 0.59076737 |
| 105 | PASK | 0.57206853 |
| 106 | CSNK1A1L | 0.54729872 |
| 107 | MAP3K1 | 0.54309894 |
| 108 | INSRR | 0.54273070 |
| 109 | PKN1 | 0.54144207 |
| 110 | MKNK2 | 0.53560664 |
| 111 | PDPK1 | 0.53499721 |
| 112 | PRKACA | 0.53494645 |
| 113 | TYRO3 | 0.52885324 |
| 114 | PDK1 | 0.52791639 |
| 115 | ERBB3 | 0.52711617 |
| 116 | PTK2B | 0.51724158 |
| 117 | RPS6KA2 | 0.51164157 |
| 118 | CAMK2G | 0.49630871 |
| 119 | BMPR2 | 0.48645423 |
| 120 | CAMK2D | 0.48444154 |
| 121 | TSSK6 | 0.47728707 |
| 122 | PRKCI | 0.47727858 |
| 123 | RAF1 | 0.47358942 |
| 124 | CAMK1G | 0.46952350 |
| 125 | MAP2K1 | 0.46619526 |
| 126 | PRKAA1 | 0.46594021 |
| 127 | RPS6KA3 | 0.45396936 |
| 128 | MAPK10 | 0.44035467 |
| 129 | MAPKAPK5 | 0.44013879 |
| 130 | MAP3K7 | 0.43683647 |
| 131 | RPS6KB1 | 0.42457205 |
| 132 | CHUK | 0.42333951 |
| 133 | PRKCA | 0.42302158 |
| 134 | ADRBK1 | 0.42014792 |
| 135 | PRKAA2 | 0.40549047 |
| 136 | PRKACB | 0.39868221 |
| 137 | MAP3K6 | 0.39494469 |
| 138 | MYLK | 0.38690665 |
| 139 | ROCK1 | 0.38517239 |
| 140 | NEK6 | 0.37620922 |
| 141 | OBSCN | 0.37112247 |
| 142 | SCYL2 | 0.36924072 |
| 143 | PRKG1 | 0.36570194 |
| 144 | CSNK1E | 0.36155972 |
| 145 | ROCK2 | 0.34335368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.32293369 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.26498806 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.21600762 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.15892544 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.15366849 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 3.14120643 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.81213484 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.80569977 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66584744 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53786152 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53195053 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.41969566 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.37745807 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 2.33650214 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.32833163 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28277386 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.14549629 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 2.13453207 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05762559 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01259886 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.95897720 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89217948 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.82568091 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81978467 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77701984 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75850515 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69533660 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62595762 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60542299 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60188004 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.59956407 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.58887380 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57569818 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.54169644 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51905481 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51843143 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50710563 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47336124 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45896406 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41987601 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41880842 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41527831 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40435410 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39681437 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38940216 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36546979 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35745436 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.35447196 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.34730843 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.33261318 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32978956 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29710455 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28780733 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25875913 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.22097164 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21157329 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21126720 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19843037 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15819213 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13679110 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12688202 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11152199 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10654513 |
| 64 | Protein export_Homo sapiens_hsa03060 | 1.09269299 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07935302 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05721026 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05698238 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05632419 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 1.04680915 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04441576 |
| 71 | Glioma_Homo sapiens_hsa05214 | 1.04293931 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01175119 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00029244 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99431473 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.98778254 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97820460 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97521399 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97130987 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.93303372 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93208233 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91758797 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90103566 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89470519 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86949140 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85033846 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84514301 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82216281 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80126871 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79025985 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78420185 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77417241 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75615665 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75004800 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74936247 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72076686 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70401544 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68543190 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68375471 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67519893 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67518804 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67362402 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66090536 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65576484 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.65162835 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62110770 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62050317 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61751525 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61190181 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60729964 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59502869 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58311030 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56539847 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56404872 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55786063 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55526648 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55268034 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55181486 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55004987 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54816239 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53683672 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.53617796 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53336413 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53068976 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51004837 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50149689 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50087119 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49205746 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49071683 |
| 129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48689885 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47408957 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.46982361 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44666032 |
| 133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44140710 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43156878 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43041297 |
| 136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42904348 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41941823 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41174553 |
| 139 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40057331 |
| 140 | Alcoholism_Homo sapiens_hsa05034 | 0.39566649 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39492262 |
| 142 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39262911 |
| 143 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38192989 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37145969 |
| 145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33471841 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32028793 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31623525 |
| 148 | Bile secretion_Homo sapiens_hsa04976 | 0.31350319 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30562044 |
| 150 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29096845 |
| 151 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27621300 |
| 152 | Tight junction_Homo sapiens_hsa04530 | 0.27505817 |

